Skip to main content
芭薇股份 logo

芭薇股份 — Investor Relations & Filings

Ticker · 920123 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2024-04-25 Governance Information
Country CN China
Listing Beijing Stock Exchange 920123

About 芭薇股份

https://www.gzbawei.com/

Guangdong Bawei Biotechnology Corp., Ltd. is a comprehensive beauty and personal care solution provider specializing in research, development, production, and testing. The company offers integrated OEM, ODM, and OBM services, covering a wide range of product categories including skincare, hair care, body care, and makeup. Bawei is recognized for its commitment to scientific innovation, operating advanced R&D laboratories and an independent third-party testing center that ensures product safety and efficacy. By leveraging automated production lines and a rigorous quality management system, the company serves a diverse portfolio of domestic and international brands. Its core focus remains on delivering high-quality, customized formulations and manufacturing excellence to meet evolving consumer demands in the global beauty market.

Recent filings

Filing Released Lang Actions
独立董事专门会议制度
Governance Information Classification · 95% confidence The document is titled as an "Independent Directors Special Meeting System" of Guangdong Bawei Biotechnology Co., Ltd. It details the governance structure, meeting procedures, voting rules, and responsibilities of independent directors. It references relevant laws, regulations, and company bylaws. The content is about internal governance rules and procedures rather than financial results, audit opinions, or announcements of meetings or votes. The document is not a report of financial performance, nor is it an announcement of a meeting or voting results. It is a governance-related document outlining internal rules and practices for independent directors' meetings. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 3376 characters, which is sufficient for a substantive governance document rather than a brief announcement.
2024-04-25 Chinese
总经理工作细则
Governance Information Classification · 95% confidence The document is titled as "广东芭薇生物科技股份有限公司总经理工作细则" which translates to "General Manager Work Rules of Guangdong Bawei Biotechnology Co., Ltd." It details the duties, appointment conditions, responsibilities, and performance evaluation of the company's general manager and other senior management personnel. The content is about internal management rules and governance practices rather than financial results, audit opinions, or shareholder meeting materials. There is no indication of financial data, earnings, voting results, or regulatory filings. The document is a governance-related internal policy document. Therefore, it fits best under Governance Information (CGR). The document length is 5474 characters, which is sufficient for a detailed governance report rather than a brief announcement or notice.
2024-04-25 Chinese
关于设立内审部并聘任内审部负责人的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the establishment of an internal audit department and the appointment of its head. It includes details about the appointee's background and the board meeting resolution approving this. There is no financial data, no report attached or referenced as being published, and no mention of financial results or regulatory certifications. The content focuses on management/board level organizational changes related to internal audit leadership. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management or board members.
2024-04-25 Chinese
关于天职国际会计师事务所（特殊普通合伙）履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is an evaluation report on the performance of the auditing firm Tianzhi International Accounting Firm for the company's 2023 annual audit. It discusses the auditor's qualifications, independence, audit procedures, and the company's assessment of the auditor's performance. The document does not contain the actual audited financial statements or detailed financial data but rather an assessment of the auditor's work and compliance with auditing standards. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and evaluations related to audit activities, excluding full annual reports. The document length is short (1303 characters), but it is not merely an announcement of a report being published; it contains substantive content about the audit firm's performance and evaluation. Therefore, the appropriate classification is AR with high confidence. FY 2023
2024-04-25 Chinese
董事会审计委员会对会计师事务所履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a report from the Audit Committee of Guangdong Bawei Biotechnology Co., Ltd. regarding the supervision of the accounting firm Tianzhi International Accounting Firm for the year 2023. It details the firm's qualifications, the committee's evaluation of the firm's performance, and the oversight activities related to the annual audit. The document does not contain the full annual report or financial statements but focuses on the audit supervision and evaluation. This matches the definition of an Audit Report / Information filing, which includes standalone audit reports and results of internal or regulatory oversight related to audits, excluding the full Annual Report. The document length is short (1351 characters), but it is a substantive report, not merely an announcement or certification. Therefore, the appropriate classification is AR (Audit Report / Information). FY 2023
2024-04-25 Chinese
董事会审计委员会 2023 年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2023年度履职情况报告" (2023 Annual Performance Report) from the Board Audit Committee of Guangdong Bawei Biotechnology Co., Ltd. It details the committee's activities, oversight of external auditors, internal audit guidance, and internal control evaluations for the year 2023. The content focuses on the audit committee's duties and their assessment of audit and control processes rather than presenting full financial statements or audit opinions. The document length is 1637 characters, which is relatively short and more consistent with a committee report rather than a full audit report or annual report. It is not an announcement of a report publication but a substantive report on the audit committee's work. This fits best with the category of Audit Report / Information (AR), which includes standalone audit reports and related information excluding full annual reports. Therefore, the classification is AR with high confidence. FY 2023
2024-04-25 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.